Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fong

Showing results (621-630 of 641) with videos related to

Pageof 65
Sort By:
Journal of Medicinal Chemistry|March 27, 2009
1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesityPetr Vachal, Joan M Fletcher, Tung M Fong, et al.
Chest|April 27, 2020
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel ReportPeter J Mazzone, Michael K Gould, Douglas A Arenberg, et al.
Journal of the American College of Radiology : JACR|June 3, 2020
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel ReportPeter J Mazzone, Michael K Gould, Douglas A Arenberg, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonistsHelen E Armstrong, Amy Galka, Linus S Lin, et al.
European Journal of Pharmacology|November 21, 2007
Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodentsLauren P Shearman, D Sloan Stribling, Ramon E Camacho, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonistQingmei Hong, Raman K Bakshi, Brenda L Palucki, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesityShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 13, 2019
Clinical management practices of life-threatening asthma: an audit of practices in intensive carePaul Secombe, Penny Stewart, Sunil Singh, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2007
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodentsTung M Fong, Xiao-Ming Guan, Donald J Marsh, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2007
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptorH Donald Burns, Koen Van Laere, Sandra Sanabria-Bohórquez, et al.
Pageof 65

Showing results (621-630 of 641) with videos related to

Sort By:
Pageof 65
Journal of Medicinal Chemistry|March 27, 2009
1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesityPetr Vachal, Joan M Fletcher, Tung M Fong, et al.
Chest|April 27, 2020
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel ReportPeter J Mazzone, Michael K Gould, Douglas A Arenberg, et al.
Journal of the American College of Radiology : JACR|June 3, 2020
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel ReportPeter J Mazzone, Michael K Gould, Douglas A Arenberg, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonistsHelen E Armstrong, Amy Galka, Linus S Lin, et al.
European Journal of Pharmacology|November 21, 2007
Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodentsLauren P Shearman, D Sloan Stribling, Ramon E Camacho, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonistQingmei Hong, Raman K Bakshi, Brenda L Palucki, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesityShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 13, 2019
Clinical management practices of life-threatening asthma: an audit of practices in intensive carePaul Secombe, Penny Stewart, Sunil Singh, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2007
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodentsTung M Fong, Xiao-Ming Guan, Donald J Marsh, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2007
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptorH Donald Burns, Koen Van Laere, Sandra Sanabria-Bohórquez, et al.
Pageof 65